Navigation Links
Absorption Pharmaceuticals Expands Sales and Service Team to Answer Physicians' Growing Demand for Promescent

LOS ANGELES, Nov. 21, 2013 /PRNewswire/ -- Absorption Pharmaceuticals (AP), the innovators behind Promescent, announced today the addition of three new experts to their national sales and support team to better cater to its growing demand from urologists and pharmacies. Word of Promescent's superior efficacy, minimal side effects, ease-of-use, and low cost per dose for treating premature ejaculation is spreading fast, so in an effort to solidify continued success and satisfaction, the company has recruited some of the most knowledgeable and qualified salespersons in the field to join their team. 

"Only 9% of men with PE seek help from their physician, so there's a lack of knowledge among patients and many urologists with the causes and latest treatment options for PE," says Jeff Abraham, CEO of Absorption Pharmaceuticals. "It's critical that our sales and service team have the experience in sexual medicine to efficiently educate physicians, PAs, and pharmacists."

Lisa Waddington joins AP as the director of Eastern U.S. regional sales, based in New York City.  She comes to AP from Bryce Rx Laboratories, one of the nation's compounding-only pharmacies, which specialized in erectile dysfunction. Lisa developed Bryce Rx's distribution of advanced ED medications, including Trimix, with hundreds of urologists across the United States.

Victoria Skrip joins AP as the director of Midwest U.S. regional sales, based in Chicago. Prior to AP, she was an award-winning urology and women's health care representative for Warner Chilcott Pharmaceuticals, based in Louisville, Kentucky.

Mary Ann Adkins joins AP as the director of physician services, based in Las Vegas. Mary Ann has extensive experience in sexual medicine, particularly with solutions following radical prostatectomy to help men regain sexual function.  She understands the physician, PA, and administrative staff goals for patient care and will bring that perspective to AP.

"I'm excited to add Lisa, Victoria and Mary Ann to the team," concludes Abraham. "Not only do they provide additional geographic coverage, but each of them provides new knowledge in the field of sexual medicine that strengthens the company's ability to serve both patient and physician."

Already, there are more than one thousand urologists across the U.S. currently using Promescent as first-line treatment for premature ejaculation, and its popularity is now also surging among sex therapists and even general practitioners.  With three sterling new additions to their sales force, Absorption Pharmaceuticals can now extend their aid and reach even further.

About Absorption Pharmaceuticals
Absorption Pharmaceuticals is the maker of Promescent, an FDA-approved, topical medication for premature ejaculation. Many key opinion leaders in sexual medicine consider Promescent the leading solution for premature ejaculation in the U.S. The California-based company has been featured in numerous media including CNBC, NBC News, Dr. Oz, the Doctors, CNN and the National Post. Learn more at

For more information, or to purchase Promescent, please visit

SOURCE Absorption Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Absorption Systems Scientists Publish Peer-reviewed Paper on a Key Drug Transporter
2. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
3. Vatsala Naageshwaran of Absorption Systems to Present at Disso 2013 International Conference in Mumbai, India on May 3rd
4. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
5. Absorption Systems Partners with Synerzys to Promote Biopharmaceutics Classification System (BCS) Testing of Drugs
6. Absorption Systems Registers with FDA as a Generic Drug Facility under GDUFA
7. Absorption Systems announces novel test platform for interactions with the BCRP transporter
8. Actinium Pharmaceuticals To Present At The LD Micro Conference
9. Acquisitions, Conference Participations, Court Rulings, and Product Deliveries - Research Report on Zoetis, Aegerion Pharmaceuticals, Edwards, Community Health Systems, and Air Methods
10. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
11. Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results
Post Your Comments:
(Date:12/1/2015)... Calif. , Dec. 1, 2015 ... products and services, announced today that it has been ... services organization. Members served by Novation will have access ... devices, sports bracing products and soft goods dedicated to ... --> The aging U.S. population, rising prevalence ...
(Date:12/1/2015)... 2015 Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country of ... registered in Europe in 2015 were tested in ... Russia has always been a country of choice for ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Growth in medical payments per workers’ compensation ... utilization of hospital and nonhospital care, according to a recent study by the Workers ... 16th Edition , found medical payments per claim with more than seven days of ...
(Date:12/1/2015)... ... December 01, 2015 , ... It’s official: Tattoo taboo is ... a number even greater among Millennials (a whopping one in three aged 18 to ... people who are dissatisfied with their ink. In fact, RealSelf , the world’s ...
(Date:12/1/2015)... ... 01, 2015 , ... For many X-rays taken at hospitals, ... interpretation by the radiologist. The marking utensils are so small, however, they are ... a way to alleviate this problem. , He developed the patent-pending MARK N ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):